Here, we studied the tumor cell-intrinsic role of KIT in three-dimensional patient-derived tumor organoids (PDOs) by generating PDO variants in which the KIT gene was either deleted (by CRISPR-Cas9-mediated gene editing), or overexpressed (by using a lentiviral expression construct). The gene discussed is KIT; the disease is neoplasm.